Published in Virchows Arch A Pathol Anat Histopathol on January 01, 1987
Study of the reactive dendritic cells in small B-cell lymphoproliferations of the skin. Virchows Arch (2007) 0.75
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood (1994) 21.00
Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology (2002) 4.22
Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol (1992) 4.04
Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med (1983) 3.63
Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology (2000) 3.24
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol (2002) 2.86
The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology (2006) 2.18
Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood (1996) 2.02
Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med (1994) 1.84
'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver. Histopathology (1996) 1.83
Recent advances in the separation and analysis of diazo-positive bile pigments. Methods Biochem Anal (1974) 1.81
Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood (1999) 1.71
Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour? Liver (1998) 1.67
A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary version. Am J Clin Pathol (1995) 1.67
Alagille syndrome (arteriohepatic dysplasia) and del(20)(p11.2) Am J Med Genet (1990) 1.61
Monomer-solvent phase separation in one-step self-etch adhesives. J Dent Res (2005) 1.60
Arsenic and non-cirrhotic portal hypertension. A report of eight cases. J Hepatol (1990) 1.59
Immunopathology of trachomatous conjunctivitis. Br J Ophthalmol (1989) 1.59
Evidence of chemical bonding at biomaterial-hard tissue interfaces. J Dent Res (2000) 1.57
Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol (1998) 1.57
Renal involvement in sarcoidosis. Postgrad Med J (1970) 1.57
Nimesulide-induced acute hepatitis: evidence from six cases. J Hepatol (1998) 1.55
Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology (2002) 1.54
Perivascular spaces in eccrine spiradenoma. A clue to its histological diagnosis. Am J Dermatopathol (1995) 1.53
Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis. Hum Pathol (1989) 1.51
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology. Eur J Cancer (2000) 1.50
Histiocytes in Sweet's syndrome. Br J Dermatol (1991) 1.49
Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities. Leukemia (2006) 1.41
t(1;19) without detectable E2A rearrangements in two t(14;18)-positive lymphoma/leukemia cases. Genes Chromosomes Cancer (1994) 1.41
Embryology of extra- and intrahepatic bile ducts, the ductal plate. Anat Rec (Hoboken) (2008) 1.41
Adverse role of the spleen in hereditary spherocytosis: evidence by the use of the atomic force microscope. Br J Haematol (1992) 1.39
Belgian consensus guidelines for follow-up of women with cervical cytological abnormalities. Acta Clin Belg (2009) 1.38
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35
Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol (1993) 1.34
Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer. J Clin Pathol (2005) 1.33
FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Leukemia (2005) 1.32
Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J Pathol (2000) 1.32
Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer (2003) 1.31
Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. J Immunol (1999) 1.30
Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol (2001) 1.29
Ductular reaction and its diagnostic significance. Semin Diagn Pathol (1998) 1.29
The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol (2000) 1.28
Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. J Invest Dermatol (2001) 1.28
Intrahepatic bile duct development in the rat: a cytokeratin-immunohistochemical study. Lab Invest (1988) 1.27
Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood (2000) 1.25
Guidelines on the standards for the training of specialised health professionals dealing with breast cancer. Eur J Cancer (2007) 1.20
Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology (2001) 1.20
Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol (2004) 1.19
Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study. Virchows Arch (2004) 1.19
Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer. Ann Oncol (2005) 1.19
Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia (1997) 1.19
Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears. Br J Haematol (1984) 1.19
The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol (2000) 1.18
The role of HEMA in one-step self-etch adhesives. Dent Mater (2008) 1.17
Origin of interfacial droplets with one-step adhesives. J Dent Res (2007) 1.17
Ultrastructural characteristics of novel epithelial cell types identified in human pathologic liver specimens with chronic ductular reaction. Am J Pathol (1992) 1.16
Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch (2001) 1.16
The pathogenesis of MALT lymphomas: where do we stand? Leukemia (2007) 1.15
Lymphocytes and Langerhans cells in the normal human cornea. Invest Ophthalmol Vis Sci (1985) 1.13
Lymphoma classification proposal: clarification. Blood (1995) 1.13
Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am J Pathol (1999) 1.11
Primary low-grade B-cell lymphoma of MALT-type occurring in the liver: a study of two cases. J Hepatol (1997) 1.11
Detection of immunoglobulin kappa light chain rearrangements by polymerase chain reaction. An improved method for detecting clonal B-cell lymphoproliferative disorders. Am J Pathol (1999) 1.10
How much do resin-based dental materials release? A meta-analytical approach. Dent Mater (2011) 1.10
Subcutaneous lymphoid hyperplasia arising at site of ethnic scarifications and mimicking subcutaneous panniculitis-like T-cell lymphoma. Virchows Arch (2001) 1.09
Anaplastic large cell lymphoma: what's in a name? J Clin Pathol (2000) 1.09
Roughness and hydrophobicity studies of nanofiltration membranes using different modes of AFM. J Colloid Interface Sci (2005) 1.07
Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis. Br J Haematol (1985) 1.06
Heparan sulfate proteoglycan expression in normal human liver. Hepatology (1995) 1.06
The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol (1997) 1.06
Immunopathogenesis of conjunctival scarring in trachoma. Eye (Lond) (1998) 1.06
Study of the usefulness and the limits of ultrasonic diagnostic criteria for diagnosis of liver tumours. Acta Gastroenterol Belg (1993) 1.06
Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol (2002) 1.05
Pericardial disease is often not recognised as a cause of chronic severe ascites. J Hepatol (2000) 1.05
Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity? Br J Haematol (2001) 1.05
Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas. Eur J Cancer (2000) 1.04
Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1. J Clin Pathol (2009) 1.04
In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study. Int Immunol (1993) 1.04
Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. Hum Pathol (1998) 1.04
Influence of the chemical structure of functional monomers on their adhesive performance. J Dent Res (2008) 1.03
Heparan sulphate proteoglycan expression in human primary liver tumours. J Pathol (1998) 1.02
Brush cytology of ductal strictures during ERCP. Acta Gastroenterol Belg (2001) 1.01
Production of monoclonal antibodies directed against antigenic determinants common to the alpha- and beta-chain of bovine brain S-100 protein. Lab Invest (1985) 1.01
T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity. J Clin Oncol (2002) 1.01
Cells with neuroendocrine features in regenerating human liver. APMIS Suppl (1991) 1.01
A study of liver biopsies and liver disease among hemophiliacs. Blood (1985) 1.00
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation. Leukemia (2007) 1.00
A cutaneous APUDoma or Merkel cell tumor? A morphologically recognizable tumor with a biological and histological malignant aspect in contrast with its clinical behavior. Cancer (1980) 1.00
Progressive intrahepatic cholestasis (Byler's disease): case report. Gut (1975) 1.00
Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis. Am J Surg Pathol (2002) 1.00
The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma. Blood (1998) 1.00
Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer (2000) 1.00
Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism. Leukemia (2010) 0.99